Over the last few years, a number of studies provided evidence that the NKG2D/NKG2DL axis plays a pivotal role in the early recognition and elimination of transformed cells, even if different mechanisms of tumor immunoescape often interfere with this pathway during cancer progression [8,9]. This evidence concerns the gene KLRK1 and cancer.